Serum level of visfatin can reflect the severity of inflammation in patients with acute cholecystitis

Annals of Surgical Treatment and Research
Jae Woo ParkSay-June Kim

Abstract

Visfatin is a key cytokine released from the pe ripheral blood mononuclear cells (PBMCs) as well as adipose tissue, and it is involved in immune response as well as inflammation. In this study, we investigated whether the serum visfatin level could be a prognostic factor for predicting the severity of inflammation in patients with acute cholecystitis. We examined the blood samples and gallbladder specimens from patients who underwent laparoscopic cholecystectomy for either acute (n = 18) or chronic cholecystitis (n = 18). We determined the visfatin levels of these samples using various procedures such as real-time polymerase chain reaction, enzyme-linked immunosorbent assay, western blotting, and immunohistochemistry. The patients with acute cholecystitis exhibited higher mRNA expression of visfatin in PBMCs, higher serum levels of visfatin, and increased protein expression of visfatin in the gallbladder specimens than in patients with chronic cholecystitis. In the in vitro model of acute cholecystitis, the mRNA expression of visfatin showed the fastest increase among the other pro-inflammatory mediators studied, including interleukin (IL)-10, tumor necrosis factor-α, IL-6, intracellular adhesion molecule-1, and ascular cell ad...Continue Reading

References

Jun 1, 1991·Gastroenterologia Japonica·K KobayashiT Toyota
Apr 1, 1993·American Journal of Surgery·G D Friedman
Feb 13, 2001·Immunity·A R de FougerollesV E Koteliansky
Dec 31, 2002·JAMA : the Journal of the American Medical Association·Robert L TrowbridgeKaveh G Shojania
May 5, 2004·The Journal of Clinical Investigation·Song Hui JiaJohn C Marshall
Dec 8, 2004·American Journal of Respiratory and Critical Care Medicine·Shui Q YeJoe G N Garcia
Dec 18, 2004·Science·Atsunori FukuharaIichiro Shimomura
May 3, 2005·The Journal of Clinical Investigation·Kathryn E Wellen, Gökhan S Hotamisligil
Jun 3, 2005·The Journal of Endocrinology·Susan KralischMathias Fasshauer
Oct 20, 2005·The Journal of Clinical Endocrinology and Metabolism·Miao-Pei ChenYau-Jiunn Lee
Jan 13, 2006·The Journal of Clinical Endocrinology and Metabolism·Peter Arner
Jun 16, 2006·The New England Journal of Medicine·Timothy E GrahamBarbara B Kahn
Jan 24, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alexander R MoschenHerbert Tilg
Feb 7, 2008·Journal of Leukocyte Biology·Tracy LukJohn C Marshall
May 12, 2009·American Journal of Surgery·Shen-Nien WangKing-Teh Lee
Jan 14, 2012·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Youngki ParkJiyoung Lee
Jun 2, 2012·Frontiers in Bioscience (Landmark Edition)·Donato F RomagnoloJohn A Milner
Jan 15, 2013·Mediators of Inflammation·Paqui G TravésSonsoles Hortelano
Sep 10, 2014·Best Practice & Research. Clinical Gastroenterology·Leonilde BonfratePiero Portincasa

❮ Previous
Next ❯

Methods Mentioned

BETA
density gradient centrifugation
PCR
transfection
enzyme-linked immunosorbent assay

Software Mentioned

ImageJ
SPSS

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here